| 11/05 | SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition .. | AQ |
| 11/05 | SAGE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financi.. | AQ |
| 11/05 | SAGE THERAPEUTICS : Announces Third Quarter 2020 Financial Results and Highlight.. | BU |
| 11/03 | SAGE THERAPEUTICS : to Present at Upcoming November Investor Conferences | AQ |
| 11/02 | SAGE THERAPEUTICS : to Present at Upcoming November Investor Conferences | BU |
| 10/23 | SAGE THERAPEUTICS : Announces Chief Executive Jeff Jonas to Undergo Scheduled Me.. | AQ |
| 10/22 | SAGE THERAPEUTICS : Announces Chief Executive Jeff Jonas to Undergo Scheduled Me.. | BU |
| 10/20 | SAGE THERAPEUTICS : to Report Third Quarter 2020 Financial Results on Thursday, .. | AQ |
| 10/19 | SAGE THERAPEUTICS : to Report Third Quarter 2020 Financial Results on Thursday, .. | BU |
| 10/16 | SAGE THERAPEUTICS : Announces Positive Interim, Topline Zuranolone Safety and To.. | AQ |
| 10/15 | SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form .. | AQ |
| 10/15 | SAGE THERAPEUTICS : Announces Positive Interim, Topline Zuranolone Safety and To.. | BU |
| 10/02 | SAGE THERAPEUTICS : Appoints Barry Greene to Board of Directors | AQ |
| 10/01 | SAGE THERAPEUTICS, INC. : Change in Directors or Principal Officers, Other Event.. | AQ |
| 10/01 | SAGE THERAPEUTICS : Appoints Barry Greene to Board of Directors | BU |
| 09/10 | SAGE THERAPEUTICS : rsquo; FutureCast to Provide Update on Pipeline Progression .. | BU |
| 09/01 | SAGE THERAPEUTICS : to Present at Morgan Stanley 18th Annual Global Healthcare C.. | BU |
| 08/20 | SAGE THERAPEUTICS : to Host Sage FutureCast Webcast | BU |
| 08/10 | SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition .. | AQ |
| 08/10 | SAGE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financi.. | AQ |
| 08/10 | SAGE THERAPEUTICS : Announces Second Quarter 2020 Financial Results and Highligh.. | BU |
| 07/30 | SAGE THERAPEUTICS : to Present at 2020 Wedbush PacGrow Healthcare Virtual Confer.. | BU |
| 07/21 | SAGE THERAPEUTICS : to Report Second Quarter 2020 Financial Results on Monday, A.. | BU |
| 06/10 | SAGE THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (f.. | AQ |
| 06/01 | SAGE THERAPEUTICS : to Present at Goldman Sachs 41st Annual Global Healthcare Co.. | BU |
| 05/11 | SAGE THERAPEUTICS : to Present at Bank of America Health Care Conference 2020 | AQ |
| 05/08 | SAGE THERAPEUTICS : to Present at Bank of America Health Care Conference 2020 | BU |
| 05/07 | SAGE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Change .. | AQ |
| 05/07 | SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition .. | AQ |
| 05/07 | SAGE THERAPEUTICS : Announces First Quarter 2020 Financial Results and Highlight.. | BU |
| 04/16 | SAGE THERAPEUTICS : to Report First Quarter 2020 Financial Results on Thursday, .. | BU |
| 04/07 | SAGE THERAPEUTICS, INC. : Costs Associated with Exit or Disposal Activities, Oth.. | AQ |
| 04/07 | SAGE THERAPEUTICS : Announces Restructuring to Advance Corporate Strategy and Pi.. | BU |
| 04/06 | SAGE THERAPEUTICS : Announces Inducement Grants Under NASDAQ Listing Rule 5635(4.. | AQ |
| 04/03 | SAGE THERAPEUTICS : Announces Inducement Grants Under NASDAQ Listing Rule 5635(c.. | BU |
| 03/18 | SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form .. | AQ |
| 03/18 | SAGE THERAPEUTICS : Announces Development Plan for Zuranolone (SAGE-217) Followi.. | BU |
| 03/04 | SAGE THERAPEUTICS : Announces Inducement Grants Under NASDAQ Listing Rule 5635(c.. | BU |
| 02/27 | SAGE THERAPEUTICS : SEC Filing (S-8) | PU |
| 02/27 | SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition .. | AQ |
| 02/27 | SAGE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financi.. | AQ |
| 02/27 | SAGE THERAPEUTICS : Announces Fourth Quarter and Full Year 2019 Financial Result.. | BU |
| 02/24 | SAGE THERAPEUTICS : to Present at the Cowen & Co. 40th Annual Health Care Confer.. | BU |
| 02/10 | SAGE THERAPEUTICS : to Report Fourth Quarter and Full Year 2019 Financial Result.. | BU |
| 02/05 | SAGE THERAPEUTICS : Announces Inducement Grants Under NASDAQ Listing Rule 5635 | AQ |
| 02/04 | SAGE THERAPEUTICS : Announces Inducement Grants Under NASDAQ Listing Rule 5635(c.. | BU |
| 01/06 | SAGE THERAPEUTICS : Announces Inducement Grants Under NASDAQ Listing Rule 5635(4.. | AQ |
| 01/03 | SAGE THERAPEUTICS : Announces Inducement Grants Under NASDAQ Listing Rule 5635(c.. | BU |
| 2019 | SAGE THERAPEUTICS : to Present at J.P. Morgan Healthcare Conference on Monday, J.. | BU |
| 2019 | SAGE THERAPEUTICS : Announces Planned Progression of SAGE-718 to Phase 2 in Hunt.. | AQ |
| 2019 | SAGE THERAPEUTICS : HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Sage The.. | PR |
| 2019 | SAGE THERAPEUTICS : Announces Planned Progression of SAGE-718 to Phase 2 in Hunt.. | BU |
| 2019 | SAGE THERAPEUTICS : Lost Money in Sage Therapeutics, Inc.? | BU |
| 2019 | Kroger, Sage take losses while Five Below, Acadia advance | AQ |
| 2019 | SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form .. | AQ |
| 2019 | SAGE THERAPEUTICS : Reports Topline Results from Pivotal Phase 3 MOUNTAIN Study .. | BU |
| 2019 | SAGE THERAPEUTICS : Announces Inducement Grants Under NASDAQ Listing Rule 5635(4.. | AQ |
| 2019 | SAGE THERAPEUTICS : Announces Inducement Grants Under NASDAQ Listing Rule 5635(c.. | BU |
| 2019 | SHAREHOLDER ALERT : Robbins LLP Is Investigating the Officers and Directors of S.. | BU |
| 2019 | SAGE THERAPEUTICS : Announces Third Quarter 2019 Financial Results and Highlight.. | BU |
| 2019 | SAGE THERAPEUTICS : to Present at the Stifel 2019 Healthcare Conference | BU |
| 2019 | SAGE THERAPEUTICS : Announces Inducement Grants Under NASDAQ Listing Rule 5635(c.. | BU |
| 2019 | SAGE THERAPEUTICS : to Report Third Quarter 2019 Financial Results on Tuesday, N.. | BU |
| 2019 | SAGE THERAPEUTICS : Announces Inducement Grants Under NASDAQ Listing Rule 5635(c.. | BU |
| 2019 | SAGE THERAPEUTICS : to Participate in J.P. Morgan Executive Conference Call Seri.. | BU |
| 2019 | SAGE THERAPEUTICS : Announces Inducement Grants Under NASDAQ Listing Rule 5635(c.. | BU |
| 2019 | SAGE THERAPEUTICS : Announces the New England Journal of Medicine Publishes Data.. | BU |
| 2019 | SAGE THERAPEUTICS : to Present at the Morgan Stanley Global Healthcare Conferenc.. | BU |
| 2019 | SAGE THERAPEUTICS : Announces Second Quarter 2019 Financial Results and Highligh.. | BU |
| 2019 | SAGE THERAPEUTICS : to Present at 2019 Wedbush PacGrow Healthcare Conference | BU |
| 2019 | SAGE THERAPEUTICS : Announces Inducement Grants Under NASDAQ Listing Rule 5635(c.. | BU |
| 2019 | SAGE THERAPEUTICS : Announces Clinical Updates and Progress Across Neuroscience .. | BU |
| 2019 | SAGE THERAPEUTICS : to Report Second Quarter 2019 Financial Results on Tuesday, .. | BU |
| 2019 | SAGE THERAPEUTICS : Announces Inducement Grants Under NASDAQ Listing Rule 5635(c.. | BU |
| 2019 | SAGE THERAPEUTICS : to Host “Sage FutureCast” Webcast | BU |
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
